Bill > SF2477

This bill makes comprehensive modifications to various aspects of health insurance, Medicare supplement benefits, prescription drug reporting, and healthcare services in Minnesota. The bill introduces several key changes, including establishing new rules for community rating of Medicare-related coverage, modifying health plan renewal and discontinuation procedures, enhancing prescription drug price transparency, and updating reporting requirements for various healthcare entities. Specifically, it requires health carriers to follow more detailed guidelines when discontinuing individual health plans, mandates that manufacturers, pharmacies, pharmacy benefit managers, and wholesale drug distributors report comprehensive information about prescription drug pricing and sales, and modifies the composition and organization of the health equity advisory and leadership council. The bill also updates requirements for public hearings when hospitals plan to close, curtail operations, or relocate services, ensuring more comprehensive public notification and participation. Additionally, it clarifies definitions related to healthcare services and introduces more stringent registration and reporting requirements for entities involved in prescription drug distribution and management, with the aim of increasing transparency and understanding of drug pricing mechanisms in Minnesota.

Business and Industry, Health and Social Services

https://www.revisor.mn.gov/bills/bill.php?b=Senate&f=SF2477&ssn=0&y=2025